Sisram Medical, Majority-Owned by Fosun, Stages $125 Million Hong Kong IPO

Sisram Medical, an Israeli aesthetic laser company, completed a $125 million IPO in Hong Kong at the low end of the range. Sisram is majority owned (66%) by Fosun Pharma. Because retail investors were especially interested in the offering, their allocation was increased to 30% of the offering, up from a planned 10%. Sisram, whose stock price has traded steady to slightly lower since the offering, is the first Israeli company to be listed in Hong Kong. More details....

Stock Symbols: (HK: 1696) (SH: 600196; HK: 02196)

Share this with colleagues:

Original Article: Sisram Medical, Majority-Owned by Fosun, Stages $125 Million Hong Kong IPO

More From BioPortfolio on "Sisram Medical, Majority-Owned by Fosun, Stages $125 Million Hong Kong IPO"

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications